Forgot Login/Password?
Complete Story
 

S.B. 172: Pharmacy Practice Act, S.B. 248: Pharmacist Drug Administration

S.B. 172: Pharmacy Practice Act Revision
A third substitute version of S.B. 172 was introduced and unanimously accepted by the 11 members of the Senate Health, Human Services, and Aging Committee at its fifth hearing on Wednesday, February 16, 2000. The bill, which will make several necessary revisions and additions to the Pharmacy Practice Act, was introduced on Tuesday, July 20, by Senator Grace Drake (R-Solon). This new legislation, which is being presented as a “clean up bill” to last year’s S.B. 66, will address several issues. The bill will provide confidentiality for a pharmacist concerning a communication made to the pharmacist in the pharmacist-patient relationship. The bill will also clarify section 4729.39 (Consult Agreements) to include an exemption for pharmacists managing the drug therapy of a patient in an institutional facility. At the hearing, Chairwoman Drake testified to the changes in the substitute version, noting that on the issue of testimonial privilege, negotiations with the Attorney General’s office has produced language to provide for testimonial privilege in civil proceedings. She also explained that the language regarding medication administration was removed and introduced in a separate “stand alone” bill. The bill is scheduled to be voted out of committee and sent to the Senate floor in this month.

S.B. 248: Pharmacist Drug Administration


Pharmacist Drug Administration On January 26, S.B. 248 was introducedby Senator Grace Drake (R-Solon). S.B. 248 will amend section 4729.01 to codify a pharmacist’s ability to administer drugs and therapeutic devices, and will require a pharmacist who seeks to administer drugs to complete a course in drug administration approved by the State Board of Pharmacy. The bill is currently being heard by the Senate Health, Human Services, and Aging Committee, and had its fourth hearing on Wednesday, April 12, where it received strong opposition from the Ohio Nurses Association and the Ohio Board of Nursing. Three nurses have testified against S.B. 248 to-date. The next hearing is scheduled for early May. Pharmacists who are interested in testifying in support of S.B. 248 should me at 614.798.0037.


Get OPA Events via RSS

Events

 August 2016 
SMTWTFS
 123456
78910
11
1213
141516
17
1819
20
21
2223
242526
27
28293031
   
August 26, 2016

Ohio Ambulatory Care Summit

793 W State Street, Columbus, Ohio 43222

August 31, 2016

Pharmacist Training Program for Immunizations

OPA Office - 2674 Federated Blvd, Columbus, OH 43235

September 11, 2016
7:00AM-4:00PM

Midwest Independent Pharmacy Expo

Makoy Center, 5462 Center Street, Hilliard, OH 43026

September 20, 2016
11:00AM

Live Webinar: Required OSHA Training for Immunizing Pharmacists

September 22, 2016
7:30AM-5:15PM

APhA's Delivering MTM Services Certificate Training Program for Pharmacists

OPA Office- 2674 Federated Blvd, Columbus, OH 43235